Champions Oncology (CSBR) Current Assets (2011 - 2026)

Champions Oncology (CSBR) has 16 years of Current Assets data on file, last reported at $19.3 million in Q3 2026.

• On a quarterly basis, Current Assets fell 8.19% year-over-year to $19.3 million in Q3 2026; TTM through Jul 2026 was $19.3 million, a 8.19% decrease from a year earlier, with the FY2026 full-year figure at $19.2 million, down 14.04% from the prior year.
• Current Assets for Q3 2026 stood at $19.3 million, roughly flat from $19.2 million in the prior quarter.
• Across five years, Current Assets topped out at $22.4 million in Q2 2025 and bottomed at $13.2 million in Q3 2024.
• Historically, Current Assets has averaged $18.0 million across 5 years, with a median of $19.3 million in 2026.
• The widest annual swing landed in 2024, when Current Assets slumped 35.17%; it then soared 63.93% in 2025.
• Year by year, Current Assets stood at $20.6 million in 2022, then slumped by 31.98% to $14.0 million in 2023, then rose by 0.48% to $14.1 million in 2024, then soared by 51.46% to $21.3 million in 2025, then retreated by 9.56% to $19.3 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $19.3 million in Q3 2026, $19.2 million in Q2 2026, and $20.2 million in Q1 2026.